Oxbridge Re Holdings
OXBRNASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $0.94 Prior regular-session close from the quote source.
- $0.91–$0.96 Regular-session low and high so far today.
- 7.0K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $0.65–$1.86 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own OXBR if Oxbridge Re is a small Cayman specialty P&C reinsurer whose value depends on disciplined underwriting, access to external capital/retrocession, and management converting recent premium growth into sustainable underwriting profits and positive operating cash flow.
OXBR price history
Loading recent earnings…
Investment thesis
What must happen next
Oxbridge’s ability to continue writing reinsurance and scale profitable business is constrained by its dwindling cash — without timely external capital or retrocession it must curtail underwriting capacity.StrengtheningMateriality: High
Cash fell from $2,135,000 (period_end 2024) to $268,000 (period_end 2025). If true, the firm can sustain or grow premiums and eventually profit; if false (no capital access), underwriting will be curtailed, revenue will stall and equity holders face dilution or run-off.
Watch: A large, immediate capital raise (equity or subordinated debt) or placement of retrocession capacity that replenishes cash and underwriting capital.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Cash fell from $2,135,000 (period_end 2024) to $268,000 (period_end 2025).
Open source ↗The company showed a material increase in reported revenue in 2025, demonstrating the ability to scale written business in the short term, but it is unproven that this revenue growth will convert into sustainable underwriting profit.StrengtheningMateriality: High
Reported revenue rose from $546,000 in 2024 to $2,577,000 in 2025, a significant year-over-year increase. Revenue growth without underwriting discipline only increases loss exposure and capital drain; sustained value requires converting growth into net_income and positive cash flow.
Watch: If the revenue increase is driven by one-off investment gains, accounting shifts, or non-renewable treaty gains rather than repeatable premium, the growth will not persist.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Reported revenue rose from $546,000 in 2024 to $2,577,000 in 2025, a significant year-over-year increase.
Open source ↗Net losses have materially narrowed from 2023 to 2025, implying progress on loss experience or cost base, but durable value requires that net_income turn persistently positive as underwriting and expense discipline continue.StrengtheningMateriality: Medium
net_income improved from -$9,910,000 (2023) to -$2,750,000 (2024) to -$2,080,000 (2025), showing a multi-year improvement trend. A sustained move to positive net_income would justify reinvesting capital and support per-share value; failure leaves shareholders exposed to recurring losses and capital erosion.
Watch: A major catastrophe loss or adverse reserve development would reverse the improvement and widen net losses again.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
net_income improved from -$9,910,000 (2023) to -$2,750,000 (2024) to -$2,080,000 (2025), showing a multi-year improvement trend.
Open source ↗Oxbridge’s equity has materially declined since earlier years, so preserving regulatory and economic capital is central; continued equity erosion would constrain growth or force dilutive capital raises.StrengtheningMateriality: Medium
StockholdersEquity moved from $16,651,000 (period_end 2021) to $5,916,000 (period_end 2025), a substantial decline. If equity stabilizes, the company can deploy capital to write profitable business; if equity continues to erode, owners face dilution or loss of underwriting capability.
Watch: A successful non-dilutive capital solution (e.g., strategic partner or retrocession) that restores underwriting capacity and capital adequacy.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
StockholdersEquity moved from $16,651,000 (period_end 2021) to $5,916,000 (period_end 2025), a substantial decline.
Open source ↗The sizable fall in Assets since 2021 suggests management has been shrinking or restructuring the balance sheet; the business’s future value depends on whether shrinkage is a disciplined run-off (reducing risk) or enforced (loss of capital/clients).HoldingMateriality: Medium
Assets declined from $17,689,000 (period_end 2021) to $8,053,000 (period_end 2025), a material reduction. A deliberate run-off that reduces risk could preserve residual value for shareholders; an enforced shrinkage due to capital pressure risks liquidation-style outcomes or heavy dilution.
Watch: A planned strategic sale of assets or business units accompanied by reinvestment into more profitable lines would make shrinkage positive.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Assets declined from $17,689,000 (period_end 2021) to $8,053,000 (period_end 2025), a material reduction.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Oxbridge’s ability to continue writing reinsurance and scale profitable business is constrained by its dwindling cash — without timely external capital or retrocession it must curtail underwriting capacity. If true, the firm can sustain or grow premiums and eventually profit; if false (no capital access), underwriting will be curtailed, revenue will stall and equity holders face dilution or run-off.
The company showed a material increase in reported revenue in 2025, demonstrating the ability to scale written business in the short term, but it is unproven that this revenue growth will convert into sustainable underwriting profit. Revenue growth without underwriting discipline only increases loss exposure and capital drain; sustained value requires converting growth into net_income and positive cash flow.
Net losses have materially narrowed from 2023 to 2025, implying progress on loss experience or cost base, but durable value requires that net_income turn persistently positive as underwriting and expense discipline continue. A sustained move to positive net_income would justify reinvesting capital and support per-share value; failure leaves shareholders exposed to recurring losses and capital erosion.
Oxbridge’s equity has materially declined since earlier years, so preserving regulatory and economic capital is central; continued equity erosion would constrain growth or force dilutive capital raises. If equity stabilizes, the company can deploy capital to write profitable business; if equity continues to erode, owners face dilution or loss of underwriting capability.
The sizable fall in Assets since 2021 suggests management has been shrinking or restructuring the balance sheet; the business’s future value depends on whether shrinkage is a disciplined run-off (reducing risk) or enforced (loss of capital/clients). A deliberate run-off that reduces risk could preserve residual value for shareholders; an enforced shrinkage due to capital pressure risks liquidation-style outcomes or heavy dilution.
All standing thesis claims
Original report summary
Oxbridge Re is a small Cayman specialty P&C reinsurer whose value depends on disciplined underwriting, access to external capital/retrocession, and management converting recent premium growth into sustainable underwriting profits and positive operating cash flow.
Bull case and bear case
Bull case and bear case for OXBRIDGE RE HOLDINGS
Where the evidence on OXBRIDGE RE HOLDINGS stands: Holding on the latest evidence (Nov 7, 2026). Of its 5 thesis points, 4 strengthening and 1 holding.
Bull case: what the evidence supports
Oxbridge’s ability to continue writing reinsurance and scale profitable business is constrained by its dwindling cash — without timely external capital or retrocession it must curtail underwriting capacity.
The company showed a material increase in reported revenue in 2025, demonstrating the ability to scale written business in the short term, but it is unproven that this revenue growth will convert into sustainable underwriting profit.
Net losses have materially narrowed from 2023 to 2025, implying progress on loss experience or cost base, but durable value requires that net_income turn persistently positive as underwriting and expense discipline continue.
Oxbridge’s equity has materially declined since earlier years, so preserving regulatory and economic capital is central; continued equity erosion would constrain growth or force dilutive capital raises.
The sizable fall in Assets since 2021 suggests management has been shrinking or restructuring the balance sheet; the business’s future value depends on whether shrinkage is a disciplined run-off (reducing risk) or enforced (loss of capital/clients).
Bear case: what would count against it
A large, immediate capital raise (equity or subordinated debt) or placement of retrocession capacity that replenishes cash and underwriting capital.
If the revenue increase is driven by one-off investment gains, accounting shifts, or non-renewable treaty gains rather than repeatable premium, the growth will not persist.
A major catastrophe loss or adverse reserve development would reverse the improvement and widen net losses again.
Thesis-Break Engine
Thesis-break watch · OXBRIDGE RE HOLDINGS
Loading the break-condition record for OXBRIDGE RE HOLDINGS.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
OXBRIDGE RE HOLDINGS filed an SEC 8-K on 2026-08-13: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedEntered a material definitive agreement.
OXBRIDGE RE HOLDINGS filed an SEC 8-K on 2026-06-22: Entered a material definitive agreement. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
OXBRIDGE RE HOLDINGS filed an SEC 8-K on 2026-05-11: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- A large, immediate capital raise (equity or subordinated debt) or placement of retrocession capacity that replenishes cash and underwriting capital.
- If the revenue increase is driven by one-off investment gains, accounting shifts, or non-renewable treaty gains rather than repeatable premium, the growth will not persist.
- A major catastrophe loss or adverse reserve development would reverse the improvement and widen net losses again.
- A successful non-dilutive capital solution (e.g., strategic partner or retrocession) that restores underwriting capacity and capital adequacy.
- A planned strategic sale of assets or business units accompanied by reinvestment into more profitable lines would make shrinkage positive.
OXBR news
Loading headlines…
Financial statements
OXBR income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
OXBR: quick answers
- Have members of Congress traded OXBR?
- 2 trades in OXBR have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed OXBR trade
